AppLovin Hits 68% Revenue Jump, Bitcoin Slides, Synth‑Med Biotech Secures Funding
TL;DR
* AppLovin Reports 68% Revenue Growth, 18% Operating Cash Decline, Highlighting Funding Tightness.
* Bitcoin Price Drops to $88.6K, Fueling Altcoin Adoption Amid Startup Funding Shifts.
* Synth‑Med Biotechnology Secures Multi‑Milestone Funding, Accelerating AI‑Driven Biotech Startups.
AppLovin’s Revenue Boom Masks a Growing Liquidity Gap
Revenue surge